NARSAD Grantee and Colleagues Create New Model for Treatment of OCD
NARSAD Grantee and Colleagues Create New Model for Treatment of OCD
Currently, there is only one type of medication that has been shown to be effective in treating Obsessive-Compulsive Disorder (OCD). Serotonin Reuptake Inhibitors (SRIs), including clomipramine, have been shown to reduce symptoms in 40% - 60% of patients with OCD. Cognitive Behavioral Therapy (CBT) has also been shown to be effective.
“Now that we have this model, we actually could pursue these ideas for better treatments in a disease where there is only one successful pharmocological monotherapy,” said NARSAD Young Investigator Grantee Stephanie Dulawa, Ph.D.
Click here to read more
Related Articles
Posted: Thursday, July 7, 2022
Posted: Monday, June 21, 2021
Posted: Thursday, September 12, 2019
Donate Now
Donations are welcome
Currently, there is only one type of medication that has been shown to be effective in treating Obsessive-Compulsive Disorder (OCD). Serotonin Reuptake Inhibitors (SRIs), including clomipramine, have been shown to reduce symptoms in 40% - 60% of patients with OCD. Cognitive Behavioral Therapy (CBT) has also been shown to be effective.
“Now that we have this model, we actually could pursue these ideas for better treatments in a disease where there is only one successful pharmocological monotherapy,” said NARSAD Young Investigator Grantee Stephanie Dulawa, Ph.D.
Click here to read more